Appendix F. Official FDA Announcement for Survey

A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising

Appendix F. Official FDA Announcement for Survey

OMB: 0910-0929

Document [docx]
Download: docx | pdf

To be posted here: https://www.fda.gov/drugadsurvey

OMB Control Number: 0910-####

Expiration Date: ##/##/####



Center for Drug Evaluation and Research

National Survey on Numerical Claims in Prescription Drug Advertising



The National Survey on Numerical Claims in Prescription Drug Advertising is designed to assess how adults interpret different claims used in prescription drug advertising. Findings from this study will help to improve claims that use numbers or “numerical” claims.

This FDA-sponsored survey uses an address-based sampling method to contact a nationally representative sample of U.S. adults. The survey is mailed to households from [month] to [month, year] and adults (18 years and older) are asked to complete the web-based survey. Participation will help improve claims made about benefits and risks in prescription drug advertising.







File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorNaomi Yount
File Modified0000-00-00
File Created2024-09-14

© 2024 OMB.report | Privacy Policy